UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 442

Sortiert nach

Worst-Rank Score Methods-A Nonparametric Approach to Informatively Missing Data

JAMA : the journal of the American Medical Association, 2020-10, Vol.324 (16), p.1670

Lachin, John M

2020

Link zum Volltext

Verfügbarkeit prüfen

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Diabetes care, 2018-02, Vol.41 (2), p.356-363

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

Diabetes (New York, N.Y.), 2014-02, Vol.63 (2), p.739-748

2014

Link zum Volltext

Verfügbarkeit prüfen

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality

JAMA : the journal of the American Medical Association, 2015-01, Vol.313 (1), p.45

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

European heart journal, 2018-02, Vol.39 (5), p.363-370

2018

Link zum Volltext

Verfügbarkeit prüfen

Large sample inference for a win ratio analysis of a composite outcome based on prioritized components

Biostatistics (Oxford, England), 2016-01, Vol.17 (1), p.178-187

2016

Link zum Volltext

Verfügbarkeit prüfen

Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study

Diabetes (New York, N.Y.), 2014-01, Vol.63 (1), p.282-290

2014

Link zum Volltext

Verfügbarkeit prüfen

Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes care, 2013-08, Vol.36 (8), p.2254-2261

2013

Link zum Volltext

Verfügbarkeit prüfen

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

Diabetes (New York, N.Y.), 2013-12, Vol.62 (12), p.3976-3986

2013

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Diabetes care, 2019-05, Vol.42 (5), p.875-882

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited

Diabetes (New York, N.Y.), 2008-04, Vol.57 (4), p.995-1001

2008

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes

Diabetes (New York, N.Y.), 2014-05, Vol.63 (5), p.1748-1762

2014

Link zum Volltext

Verfügbarkeit prüfen

Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales

PloS one, 2014-10, Vol.9 (10), p.e108784-e108784

2014

Link zum Volltext

Verfügbarkeit prüfen

Fallacies of last observation carried forward analyses

Clinical trials (London, England), 2016-04, Vol.13 (2), p.161-168

Lachin, John M

2016

Link zum Volltext

Verfügbarkeit prüfen

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

The New England journal of medicine, 2006-12, Vol.355 (23), p.2427-2443

2006

Link zum Volltext

Verfügbarkeit prüfen

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

Cardiovascular diabetology, 2014-06, Vol.13 (1), p.102-102

2014

Link zum Volltext

Verfügbarkeit prüfen

A review of methods for futility stopping based on conditional power

Statistics in medicine, 2005-09, Vol.24 (18), p.2747-2764

Lachin, John M.

2005

Link zum Volltext

Verfügbarkeit prüfen

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

Diabetes & vascular disease research, 2015-05, Vol.12 (3), p.164-174

2015

Link zum Volltext

Verfügbarkeit prüfen

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study

Clinical journal of the American Society of Nephrology, 2016-11, Vol.11 (11), p.1969-1977

2016

Link zum Volltext

Verfügbarkeit prüfen

Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

Diabetes care, 2007-10, Vol.30 (10), p.2453-2457

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

Diabetes care, 2010-05, Vol.33 (5), p.1090-1096

2010

Link zum Volltext

Verfügbarkeit prüfen

Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes

PloS one, 2019-01, Vol.14 (1), p.e0210367-e0210367

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes

Diabetes care, 2006-09, Vol.29 (9), p.2102-2107

2006

Link zum Volltext

Verfügbarkeit prüfen

Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies

PloS one, 2021-11, Vol.16 (11), p.e0257154-e0257154

2021

Link zum Volltext

Verfügbarkeit prüfen

Power and sample size evaluation for the Cochran-Mantel-Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend

Statistics in medicine, 2011-11, Vol.30 (25), p.3057-3066

Lachin, John M.

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 442

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(372)
Mit Volltextzugriff
(417)

Publikationsform

Sprache

Englisch
(442)
Japanisch
(58)

Erscheinungsjahr

n.n

Thema

Science & Technology
(259)
Life Sciences & Biomedicine
(251)
Humans
(243)
Diabetes
(140)
Male
(138)
Female
(135)
Endocrinology & Metabolism
(117)
Adult
(114)
Risk Factors
(102)
Diabetes Mellitus
(83)
Middle Aged
(78)
Biological And Medical Sciences
(75)
Medical Sciences
(73)
Mathematics
(70)
Diabetes Mellitus, Type 1 - Complications
(64)
Epidemiology
(53)
Research Design
(53)
Adolescent
(52)
Young Adult
(51)
Diabetes Mellitus, Type 1 - Drug Therapy
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes Care
(85)
Diabetes
(50)
Statistics In Medicine
(31)
Controlled Clinical Trials
(24)
The New England Journal Of Medicine
(18)
Circulation
(12)
Biometrics
(11)
Clinical Trials
(9)
Plos One
(8)
Clinical Chemistry
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Worst-Rank Score Methods-A Nonparametric Approach to Informatively Missing Data

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

Large sample inference for a win ratio analysis of a composite outcome based on prioritized components

Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study

Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited

Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes

Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales

Fallacies of last observation carried forward analyses

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

A review of methods for futility stopping based on conditional power

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study

Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes

Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes

Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies

Power and sample size evaluation for the Cochran-Mantel-Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend

Suchergebnisse filtern